Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Powers, Fiona T (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252120, C514S254110, C514S255030, C540S575000, C544S395000, C544S398000, C544S402000
Reexamination Certificate
active
07968538
ABSTRACT:
The invention relates to 5-HT6receptor antagonists. Novel arylamine compounds and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating obesity, and obesity-related disorders, e.g., cardiovascular disease, digestive disease, respiratory disease, cancer and type II diabetes; and psychological disorders such as schizophrenia, are disclosed.
REFERENCES:
patent: 3236891 (1966-02-01), Seemuller
patent: 5332739 (1994-07-01), Katakami et al.
patent: 5627077 (1997-05-01), Dyllick-Brenzinger et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 6391871 (2002-05-01), Olney et al.
patent: 6455544 (2002-09-01), Friedhoff et al.
patent: 6579870 (2003-06-01), Jacobsen et al.
patent: 6608088 (2003-08-01), Nicolodi et al.
patent: 6610713 (2003-08-01), Tracey
patent: 6972287 (2005-12-01), Augelli-Szafran et al.
patent: 7030240 (2006-04-01), Dhanoa et al.
patent: 7105540 (2006-09-01), Friedhoff et al.
patent: 7153858 (2006-12-01), Dhanoa et al.
patent: 7407966 (2008-08-01), Dhanoa et al.
patent: 2003/0095958 (2003-05-01), Bhisetti et al.
patent: 2004/0076648 (2004-04-01), Williams et al.
patent: 2004/0122090 (2004-06-01), Lipton
patent: 2004/0220235 (2004-11-01), Augelli-Szafran et al.
patent: 2005/0143350 (2005-06-01), Seed
patent: 2005/0209218 (2005-09-01), Meyerson et al.
patent: 2005/0222093 (2005-10-01), Pearlman et al.
patent: 2005/0222175 (2005-10-01), Dhanoa et al.
patent: 2005/0222176 (2005-10-01), Dhanoa et al.
patent: 2005/0256153 (2005-11-01), Dhanoa et al.
patent: 2006/0018839 (2006-01-01), Ieni et al.
patent: 2006/0063810 (2006-03-01), Vergez et al.
patent: 2006/0069094 (2006-03-01), Bonhaus et al.
patent: 2006/0079547 (2006-04-01), Dhanoa et al.
patent: 2006/0084805 (2006-04-01), Dhanoa et al.
patent: 2006/0148721 (2006-07-01), Erondu
patent: 2006/0183733 (2006-08-01), Wills
patent: 2006/0194723 (2006-08-01), Rabinoff
patent: 2006/0234998 (2006-10-01), Dhanoa et al.
patent: 2006/0240043 (2006-10-01), Meyerson et al.
patent: 2006/0270647 (2006-11-01), Coric et al.
patent: 2006/0270650 (2006-11-01), MacNeil et al.
patent: 2007/0004742 (2007-01-01), Dhanoa et al.
patent: 2007/0173487 (2007-07-01), Saha et al.
patent: 2008/0015177 (2008-01-01), Saha et al.
patent: 2008/0027036 (2008-01-01), Burli et al.
patent: 2008/0027066 (2008-01-01), Dhanoa et al.
patent: 2008/0176854 (2008-07-01), Aschenbrenner et al.
patent: 2009/0042904 (2009-02-01), Aschenbrenner et al.
patent: 2512243 (2004-09-01), None
patent: WO-00/40554 (2000-07-01), None
patent: WO 00/78728 (2000-12-01), None
patent: 0198279 (2001-12-01), None
patent: WO 01/98279 (2001-12-01), None
patent: WO 02/092585 (2002-11-01), None
patent: WO 2003/024448 (2003-03-01), None
patent: WO 03/080060 (2003-10-01), None
patent: WO 2004/009600 (2004-01-01), None
patent: WO 2004/078732 (2004-09-01), None
patent: WO 2005/013977 (2005-02-01), None
patent: 2005116025 (2005-12-01), None
patent: WO 2005/116025 (2005-12-01), None
patent: WO-2006/071960 (2006-07-01), None
Zotova et al., Russian Journal of Organic Chemistry, 41(2), 214-217, 2005.
Machii et al., Chemical Abstracts, 139:307788, 2003.
Watanabe et al., Chemical Abstracts, 124:202301, 1996.
Ye et al., Bioorganic and Medicinal Chemistry Letters, 14, 761-765, 2004.
Bentley, J.C., et al., “5-HT6Antisense Oligonucleotide I.C.V. Affects Rat Performance in the Water Maze and Feeding,” J. Psychopharmacol. Suppl. A64, p. 255.
Bentley, J.C., et al., “Effect of the 5-HT6Antagonist, Ro 04-6790 On Food Consumption in Rats Trained to a Fixed Feeding Regime,” (1999) Br J Pharmac. Suppl. 126 p. 66.
Database Registry [Online] Chemical Abstracts Service, Columbus, OH, US; Chemical Library; Supplier: TimTec, Inc., Jul. 29, 2004, XP002383373.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: TOSLab, Jun. 14, 2002, XP002383407.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: TimeTec, Inc., Sep. 28, 2001, XP002383408.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: Chem Bridge Corp., Sep. 28, 2001, XP002383409.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: MicroChemistry Ltd., Jul. 22, 2001, XP002383410.
Database Registry [Online] Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: MicroChemistry Ltd. Jul. 22, 2001, XP 002385315.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: Interbioscreen Ltd., Jul. 22, 2001, XP002383411.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: Scientific Exchange, Jul. 19, 2001, XP002383412.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: MicroChemistry Ltd. Apr. 5, 2001, XP002383413.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; Chemical Library; Supplier: ChemDiv., Inc., Jan. 3, 2001, XP002383414.
Holenz, Jorg, et al., “Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6Receptor Ligants,” J Med Chem. 2005, 48, 1781-1795.
Isaac, Methvin, et al., “6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-Bicyclopiperidinyl-1-Arylsulfonylindoles Derivatives as Novel, Potent, and Selective 5-HT6Receptor Antagonists,” (2000) Bioorganic & Medicinal Chemistry Letters 10: 1719-1721.
Ruat, M., et al. “A Novel Rat Serotinin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation ofcAMP Accumulation,” (1993) Biochem Biophys. Res. Commun. 193: 268-276.
Sebben, Michele, et al., “5-HT6Receptors Positively Coupled to Adenylyl Cyclase in Striatal Neurones in Culture,” (1994) NeuroReport 5: 2553-2557.
International Search Report, International Application No. PCT/US2006/002718, mailed Jul. 5, 2006.
PCT International Preliminary Report on Patentability, International Application No. PCT/US2006/002718, issued Jul. 31, 2007.
Becker Oren
Cheruku Srinivasa Rao
Dhanoa Dale S.
Fichman Merav
Lobera Mercedes
Galenea Corp.
Lando & Anastasi LLP
Powers Fiona T
LandOfFree
Substituted arylamine compounds and methods of treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylamine compounds and methods of treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylamine compounds and methods of treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663350